How much does tirzepatide cost without insurance?

If you do not have insurance coverage for weight-loss medication — and most people do not — the price of tirzepatide depends almost entirely on which route you take to get it. The same active molecule can cost you anywhere from under $200 to more than $1,000 a month. Understanding why is the difference between overpaying and not.

Brand-name tirzepatide: Zepbound and Mounjaro

Zepbound (tirzepatide for weight management) has a list price of about $1,086 per month for a 28-day supply, and that list price is the same across every dose from 2.5 mg to 15 mg, according to Eli Lilly's published out-of-pocket pricing. Mounjaro, the same molecule approved for type 2 diabetes, is priced similarly. If you have commercial insurance that covers the drug and you use a manufacturer savings card, your out-of-pocket cost can drop dramatically — sometimes to as low as $25 a month. The problem is that a large share of plans exclude obesity medications entirely, which is what pushes most people toward cash-pay options in the first place.

Manufacturer-direct vials: LillyDirect

Eli Lilly now sells single-dose tirzepatide vials directly to cash-pay patients through LillyDirect. As of December 1, 2025, those self-pay vials run $299 for the 2.5 mg dose, $399 for 5 mg, and $449 for the 7.5 mg dose and higher, provided you refill on the required cadence. This is an FDA-approved finished product at a cash price well below the brand list price, and it has compressed the savings gap that used to make compounded versions the obvious budget choice.

Compounded tirzepatide through telehealth

Compounded tirzepatide uses the same active molecule but is prepared by a US-licensed compounding pharmacy under a prescription, rather than manufactured as a finished product by Eli Lilly. Across the telehealth market, compounded tirzepatide has ranged from roughly $125 to $699 a month. The appeal is a lower entry cost and no insurance prior-authorization delays. The important caveat: compounded medications are not FDA-approved or evaluated for safety, efficacy, or quality as finished products, and a licensed provider must determine that a compounded preparation is clinically appropriate for you. StaveMD's compounded tirzepatide program starts at $179 a month.

What a telehealth GLP-1 program usually includes

Cash-pay telehealth programs are typically quoted as a starting monthly price that bundles the provider visit, your prescription, and shipping, with no insurance required. What's included varies by program, and your provider may adjust your dose over time, so it's worth understanding what a plan covers and how dose changes are handled before you start.

• Brand-name Zepbound: about $1,086/month list; as low as ~$25/month with covered insurance plus a savings card
• LillyDirect self-pay vials (FDA-approved): $299 (2.5 mg), $399 (5 mg), $449 (7.5 mg and up) as of December 2025
• Compounded tirzepatide via telehealth: roughly $125–$699/month; StaveMD starts at $179/month
• Most telehealth programs bundle the provider visit, medication, and shipping into one monthly price — no insurance required

So which is cheapest for you?

If you have insurance that covers Zepbound or qualify for a Lilly savings card, brand-name tirzepatide may be the cheapest and comes with the assurance of an FDA-approved finished product. If you are paying cash, compare LillyDirect's vials against a compounded program and weigh cost against the fact that compounded products are not FDA-approved. Either way, the right answer depends on your coverage and your dose.